IP Library Granted Patent US 10,987,326
Granted Patent B2
US 10,987,326 · App. 16/458,233 · Granted Apr 27, 2021

Butyrate and beta-hydroxybutyrate compositions

Inventor: Franco Cavaleri (Surrey, CA)
A61K31/19A61K36/82A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,987,326
App. No.
16/458,233
Granted
Apr 27, 2021
Kind
B2
Abstract

Compositions and methods for providing a person with an exogenous and therapeutically effective supply of ketones are disclosed. The compositions may consist essentially of (a) purified butyrate (or esters or propionate salts thereof) and (b) purified beta-hydroxybutyrate (or esters or propionate salts thereof). The compositions may further include other pharmacologically active agents, such as acetyl-L carnitine, R-alpha lipoic acid, green tea extract, vitamins, and various combinations of such agents. The methods include providing a person with an exogenous supply of ketones, by orally administering a pharmacologic composition, which is effective to deliver 2000-5000 mg of a short chain fatty acid (e.g., butyrate) and 5000-10,000 mg of ketone (e.g., beta-hydroxybutyrate) on a daily basis.

Claims (13)

1. A composition comprising:

(a) purified butyrate or esters or propionate salts thereof, wherein the purified butyrate includes a butyrate sodium salt, a butyrate calcium salt, or a butyrate magnesium salt; and

(b) purified beta-hydroxybutyrate or esters or propionate salts thereof, wherein the purified beta-hydroxybutyrate includes a beta-hydroxybutyrate sodium salt, a beta-hydroxybutyrate calcium salt, or a beta-hydroxybutyrate magnesium salt, wherein the composition is packaged in a form selected from the group consisting of (i) an oral capsule, (ii) in powdered form, (iii) in an aqueous or non-aqueous liquid, (iv) in an oil-in-water or water-in-oil emulsion, (v) in an elixir or syrup, or (vi) in a paste, wherein the composition is effective to deliver 1000- 5000 mg of a short chain fatty acid and 1000-10,000 mg of ketone to a person on a daily basis.

2. The composition of claim 1 , which further comprises an agent selected from the group consisting of acetyl-L carnitine, R-alpha lipoic acid, and green tea extract.

3. The composition of claim 1 , which further comprises one or more vitamins.

4. The composition of claim 1 , which further comprises one or more preservatives.

5. The composition of claim 1 , wherein the total purified butyrate to total purified beta-hydroxybutyrate ratio is about 1:1.

6. A method for providing a person with an exogenous supply of ketones, by orally administering a composition of claim 1 to the person, which is effective to deliver 1000-5000 mg of a short chain fatty acid and 1000-10,000 mg of ketone on a daily basis.

7. The method of claim 6 , wherein the composition further comprises an agent selected from the group consisting of acetyl-L carnitine, R-alpha lipoic acid, and green tea extract.

8. The method of claim 6 , wherein the composition further comprises one or more vitamins.

9. The method of claim 6 , wherein the composition further comprises one or more preservatives.

10. The method of claim 6 , wherein the total purified butyrate to total purified beta-hydroxybutyrate ratio is about 1:1.

11. The method of claim 6 , wherein the total purified butyrate to total purified beta-hydroxybutyrate ratio is about 2:1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2024
From: CAVALERI, FRANCO
To: CAVALERI HEALTH, INC.
Reel/Frame 067798/0863 →
Continuity (3)
Continuation 15187823 · Jun 21, 2016
Provisional Application 62317607 · Apr 3, 2016
Related Publication 20190380982A1 · Dec 19, 2019
Cited By (1)
US 12,208,074